Talk:25E-NBOMe

Latest comment: 10 years ago by BDD in topic Requested move

Requested move

edit
The following discussion is an archived discussion of the proposal. Please do not modify it. Subsequent comments should be made in a new section on the talk page. No further edits should be made to this section.

The result of the proposal was moved. --BDD (talk) 17:12, 26 March 2014 (UTC)Reply

2C-E-NBOMe25E-NBOMe – The title 2C-E-NBOMe should be changed to the accepted Braden-nomenclature (Mol. Pharmacol. 2006, 70(6), 1956-1964, doi:10.1124/mol.106.028720) which uses the format 25X-NBYYY, where '25' denotes that the two methoxy groups are in the 2 and 5 position, the 'X' is the 4-sustituent usually a halogen, alkyl or thioalkyl group and is named using the same nomenclature as Alexander Shulgin uses in Pihkal for '2C-X' compounds e.g. C for chlorine, D, for methyl, T2 for thioethyl etc. The N-benzyl part of the molecule is described by the 'NBOMe' which means 2-methoxybenzyl, 'NBF' means 2-fluorobenzyl, 'NBOH' means 2-hydroxybenzyl, 'NBMD' means 2,3-methylenedioxybenzyl etc. Other naming schemes include a combination of Shulgin and Braden nomenclature e.g '2C-E-NBOMe' and 'NBOMe-2C-E' both of which are non-canonical and contribute to the confusion between simple phenethylamines such as 2C-E and their N-benzyl counterparts i.e. 25E-NBOMe. Not only is it annoying that articles exist using alternate naming schemes, the use of the non-canonical terms makes it more difficult for users to distinguish between compounds that may be 100 fold more potent and this confusion has led to overdoses in the past. --Relisted. Xoloz (talk) 17:40, 18 March 2014 (UTC) 109.56.219.194 (talk) 09:47, 25 February 2014 (UTC)Reply

The above discussion is preserved as an archive of the proposal. Please do not modify it. Subsequent comments should be made in a new section on this talk page. No further edits should be made to this section.